| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/03/2008 | WO2008077241A1 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections |
| 07/03/2008 | WO2008077194A1 Receptor agonists |
| 07/03/2008 | WO2008027162A3 129xe biosensors and their use |
| 07/03/2008 | WO2008019289A3 Tetrazolyl macrocyclic hepatitis c serine protease inhibitors |
| 07/03/2008 | WO2008015218A3 Method for diagnosis of a disease involving an anti-at1-receptor antibody |
| 07/03/2008 | WO2007117794A3 Glycated peptides and methods of use |
| 07/03/2008 | WO2007070509A3 Epithelial sodium channel inhibiting agents and uses therefor |
| 07/03/2008 | US20080161246 Cytochrome P450 Oxidase Inhibitors and Uses Thereof |
| 07/03/2008 | US20080161245 Anthracycline-oligopeptide derivatives which have a protein-binding group such as maleimide and said oligopeptide is cleavable by the prostate-specific antigen (PSA); treating cancer |
| 07/03/2008 | US20080161232 C5a Receptor Antagonist |
| 07/03/2008 | US20080161191 Nucleic Acid Fragments Encoding Proteins Involved In Stress Response |
| 07/03/2008 | US20080160571 Antibodies that bind TNF-alpha converting enzyme |
| 07/03/2008 | US20080160501 Plasma protein-binding ligands |
| 07/03/2008 | US20080160030 Anti-Interferon Alpha Monoclonal Antibodies and Methods for Use |
| 07/03/2008 | US20080159996 Using zinc finger protein nuclease as therapeutic tool in treatment and prevention of viral infection |
| 07/03/2008 | US20080159993 Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
| 07/03/2008 | CA2673678A1 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections |
| 07/03/2008 | CA2673248A1 Novel peptides |
| 07/02/2008 | EP1939286A1 Novel peptides |
| 07/02/2008 | EP1938830A1 Novel exendin agonist compounds |
| 07/02/2008 | EP1937711A1 Epitopes, combined epitopes, use of epitopes or their combination, composition, uses of the composition, anti- hiv-i prophylactic vaccines, therapeutic vaccines, method for the identification of epitopes and methods for treatment and prevention |
| 07/02/2008 | EP1937710A1 Kinin b1 receptor peptide agonists and uses thereof |
| 07/02/2008 | EP1558354A4 Using amines or amino acids as mobile phase modifiers in chromatography |
| 07/02/2008 | EP1392731B1 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 07/02/2008 | CN101210044A Polypeptide and application thereof |
| 07/02/2008 | CN100398555C Protease inhibitors for coronaviruses and SARS-COV and the use thereof |
| 07/01/2008 | US7393929 Inhibitors of cellulolytic, xylanolytic and β-glucanolytic enzymes |
| 07/01/2008 | US7393920 Deprotecting amino acid linked to solid phase resin by admixing with solution in transparent vessel while irradiating with microwaves, coupling/activating/hybridizing amino acids, then cleaving |
| 07/01/2008 | US7393835 Peptide inhibitors of protein kinase C |
| 07/01/2008 | US7393824 Methods of peptide preparation |
| 07/01/2008 | US7393529 Antiallergens |
| 07/01/2008 | US7393523 Peptides for active anti-cytokine immunization |
| 06/26/2008 | WO2008076324A2 Compositions and methods to treat muscular & cardiovascular disorders |
| 06/26/2008 | WO2008075684A1 Antibiotic glycopeptide derivative |
| 06/26/2008 | WO2008046228A8 Compounds for stimulating p-glycoprotein function and uses thereof |
| 06/26/2008 | US20080153915 Pharmaceutical Preparation For the Oral Cavity |
| 06/26/2008 | US20080153759 Treatment methods using polypeptides related to amyloid precursor protein |
| 06/26/2008 | US20080153756 Nucleic acids encoding them; for use in modulating alpha 4 integrin function; kits; antibodies against the peptides |
| 06/26/2008 | US20080153754 Phenotypic reversion of pancreatic carcinoma cells |
| 06/26/2008 | US20080153752 artificial polypeptides as inhibitor of hyaluronic acid, chondroitin sulfate A, chondroitin sulfate C, dermatan sulfate, heparin, keratan sulfate, keratosulfate, chitin, chitosan 1, and chitosan 2; for treatment of inflammatory diseases, tumor, cancer, cancer metastasis, and autoimmune diseases |
| 06/26/2008 | US20080153742 Fas peptide mimetics and uses thereof |
| 06/26/2008 | US20080153112 identification of a predominant ligand of CD8+ T cells that are responsible eq for type 1 diabetes. That ligand is islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP). Several CD8+ T cell-binding peptides from IGRP are identified, including the peptide comprising amino acids |
| 06/26/2008 | US20080152703 Epitopes formed by non-covalent association of conjugates |
| 06/26/2008 | US20080152702 Improved blood circulation lifetime of drug-carrying liposomes having a surface coating of releasable hydrophilic polymer covalently and reversibly linked to an phospholipid or polypeptide through a dithiobenzyl linkage |
| 06/26/2008 | US20080152701 Methods and Compositions for the Treatment and Prevention of Staphylococcus Infections |
| 06/26/2008 | US20080152663 Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer |
| 06/26/2008 | US20080152660 Anti-Angiogenic Compounds |
| 06/26/2008 | US20080152631 Cancer Antigen Peptides Derived from Wt1 |
| 06/25/2008 | EP1934258A1 Antibodies against april as biomarkers for early prognosis of lymphoma patients |
| 06/25/2008 | EP1485345B1 Urokinase inhibitors, production and use thereof |
| 06/25/2008 | EP1322321B1 Use of S-[2,3-Bispalmitoyloxy-(2RS)-propyl]cysteinyl-GNNDESNISFKEK (MALP-2) |
| 06/25/2008 | EP1230261B1 Ny-eso-1 nonapeptide derivatives, and uses thereof |
| 06/25/2008 | EP1117687B1 Compositions and methods for wt1 specific immunotherapy |
| 06/25/2008 | EP0859625B1 Composition and methods for enhancing immune responses mediated by antigen-presenting cells |
| 06/25/2008 | CN101205251A Chinese south China sea signal taro snail nerve toxin gene Lt3.2 and uses thereof |
| 06/25/2008 | CN100397082C HCV-free-blood external preparing method |
| 06/25/2008 | CN100396695C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 06/24/2008 | US7392141 Polypeptides; genetic engineering |
| 06/24/2008 | US7390879 Conjugation/biochemical; fibroblast growth factors |
| 06/24/2008 | US7390875 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 06/24/2008 | US7390874 Peptide, method of production thereof, and pharmaceutical composition containing the same |
| 06/24/2008 | US7390873 Microbiocides; bactericides |
| 06/24/2008 | US7390870 Immune-enhancing peptides |
| 06/24/2008 | US7390788 Pharmaceutically active peptide T composition comprising non-aggregated D-ala1-Peptide T-amide, produced by suspending the D-ala1-Peptide T-amide in 80% trifluoroethanol for 24 hours at 37 C with shaking, removing trifluoroethanol, and suspending the D-ala1-Peptide T-amide in aqueous solution |
| 06/24/2008 | US7390787 Comprising 8 to 25 amino acids and containing the formula: RXZXXZXB wherein Z is proline or valine; X is a hydrophobic residue; and B is a basic amino acid. |
| 06/24/2008 | US7390785 Amino acid sequences; from venom of snails; analgesics |
| 06/24/2008 | US7390784 Binary complexes formed have an enlarged target binding surface area and thus exhibit increased affinity, specificity or selectivity as compared to free drug forms |
| 06/24/2008 | US7390781 Methods of using truncated glial cell line-derived neurotrophic factor |
| 06/24/2008 | US7390624 For immunoglobulin detection; for diagnosis of human immunodeficiency virus and hepatitis virus; solid phase synthesis |
| 06/19/2008 | WO2008074035A1 Hcv protease inhibitors and uses thereof |
| 06/19/2008 | WO2008073368A1 Peptide-based hair protectants |
| 06/19/2008 | WO2008072676A1 Novel disease marker and diagnosis using the same |
| 06/19/2008 | WO2008071679A1 Fibrin binding peptide conjugates for diagnostic and therapeutic applications. |
| 06/19/2008 | WO2008071081A1 Preparation of low bleeding anticoagulant fusion protein and its use |
| 06/19/2008 | WO2008071009A1 Novel ligand guided block copolymers for targeted drug delivery |
| 06/19/2008 | WO2008049974A8 Peptide vaccine for influenza virus |
| 06/19/2008 | WO2008047370A3 Compositions and methods for inducing angiogenesis |
| 06/19/2008 | US20080146779 Novel Melanocortin Receptor Templates, Peptides, and Use Thereof |
| 06/19/2008 | US20080146522 Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules |
| 06/19/2008 | US20080146511 method of peptides, peptides, method and kit for the identification of infections by Mycobacterium leprae, as well as to pharmaceutical and immunological compositions containing as active principle(s), peptide(s) of Mycobacterium leprae or sequences functionally similar |
| 06/19/2008 | US20080146510 For suppressing cell proliferation/tumor growth or modulating immune system by transformation of T-lymphocytes or enhancement of natural killer cells |
| 06/19/2008 | US20080146499 Identification of the Precise Amino Acid Sequence of the Epitope Recognized by the Potent Neutralizing Human Anti-Hiv-1 Monoclonal Antibody Igg1b12 |
| 06/19/2008 | US20080145884 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 06/19/2008 | US20080145379 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 06/19/2008 | DE102006059294A1 Methylation inhibitor for eukaryotic nucleic acids comprises a peptide with a sequence of up to 17 amino amino acids, including a defined sequence |
| 06/19/2008 | CA2671971A1 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
| 06/18/2008 | EP1933150A1 Methods of screening of PP1-interacting polypeptides or proteins, peptides inhibiting PP1c binding to Bcl-2 proteins, BCL-XL and BCL-W, and uses thereof |
| 06/18/2008 | EP1932853A1 Novel depsipeptides and process for preparing same |
| 06/18/2008 | EP1932852A1 Novel taxane related peptides and uses thereof |
| 06/18/2008 | EP1932539A2 Signal-1/Signal-2 bifunctional peptide inhibitors |
| 06/18/2008 | EP1931696A1 ARYIiALKYL AND HETEROARYLALKYL DERIVATIVES OF CYCLOSPORINE A FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTION |
| 06/18/2008 | EP1931695A1 Prion-specific peptoid reagents |
| 06/18/2008 | EP1931377A1 Cd4+ t survivin epitopes and uses thereof |
| 06/18/2008 | EP1537230A4 Fluorescent enzyme assay methods and compositions |
| 06/18/2008 | EP1228203B1 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 06/18/2008 | EP1129106B1 Cyclised conotoxin peptides |
| 06/18/2008 | CN101203527A Backbone cyclized melanocortin stimulating hormone (alpha MSH) analogs |
| 06/17/2008 | US7388072 Melanoma Associated antigen (MAGE) tumor associated genes, nucleic acids encoding such peptides and antibodies relating thereto; Human Leukocyte Antigen (HLA) |
| 06/17/2008 | US7388071 Telomerase peptide is modified to enhance binding to a major histocompatibility complex (MHC) molecule |
| 06/17/2008 | US7388017 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |